Ethan Shevach, M.D.

Ethan Shevach, M.D.

Dr. Ethan Shevach is Chief of the Cellular Immunology Section at the National Institute of Allergy and Infectious Disease (NIAID). The major focus of his lab over the past decade has been furthering their understanding of the function of the subpopulation of CD4+ T cells that express the transcription factor Foxp3. These cells, which are known as regulatory T cells (Treg), suppress immune responses. Dr. Shevach’s group was one of the first in the world to realize the importance of Tregs and performed many of the initial studies that described their phenotype and function. Dr. Shevach’s lab is also working to identify molecules that enhance or reverse Treg suppression. A major goal in these studies is the development of novel biologics that modulate Treg function.

Dr. Shevach received his M.D. from Boston University in 1967. Following clinical training, he joined the Laboratory of Immunology at NIAID as a senior staff fellow in 1972, was appointed a senior investigator in 1973, and became a section chief in 1987. Dr. Shevach served as editor-in-chief of the Journal of Immunology from 1987 to 1992 and editor-in-chief of Cellular Immunology from 1996 to 2007.

• Lieping Chen, M.D., Ph.D.
• Mario Sznol, M.D.

• Ethan Shevach, M.D.

• Stephen Miller, Ph.D.